Orazio Fortunato

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Long Noncoding Rna

Top Venues

Pharmaceuticals (Basel, Switzerland)

Cell death & disease

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ilaria Petraroia, Patrizia Ghidotti, Giulia Bertolini, Francesca Pontis, Luca Roz, Melissa Balsamo, Paola Suatoni, Ugo Pastorino, Anna Maria Ferretti, Gabriella Sozzi, Orazio Fortunato
Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling. Cell death & disease 14 (10) (2023)
Michela Casanova, Francesca Pontis, Patrizia Ghidotti, Ilaria Petraroia, Lara Veronica Venturini, Luca Bergamaschi, Stefano Chiaravalli, Loris De Cecco, Maura Massimino, Gabriella Sozzi, Andrea C Ferrari, Orazio Fortunato, Patrizia Gasparini
MiR-223 Exclusively Impairs In Vitro Tumor Growth through IGF1R Modulation in Rhabdomyosarcoma of Adolescents and Young Adults. International journal of molecular sciences 23 (22) (2022)
Massimo Moro, Orazio Fortunato, Giulia Bertolini, Mavis Mensah, Cristina Borzi, Giovanni Centonze, Francesca Andriani, Daniela Di Paolo, Patrizia Perri, Mirco Ponzoni, Ugo Pastorino, Gabriella Sozzi, Mattia Boeri
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway. Pharmaceuticals (Basel, Switzerland) 15 (3) (2022)
Orazio Fortunato, Veronica Huber, Miriam Segale, Agata Cova, Viviana Vallacchi, Paola Squarcina, Licia Rivoltini, Paola Suatoni, Gabriella Sozzi, Ugo Pastorino, Mattia Boeri
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (11) (2022)
Daniela Di Paolo, Francesca Pontis, Massimo Moro, Giovanni Centonze, Giulia Bertolini, Massimo Milione, Mavis Mensah, Miriam Segale, Ilaria Petraroia, Cristina Borzi, Paola Suatoni, Chiara Brignole, Patrizia Perri, Mirco Ponzoni, Ugo Pastorino, Gabriella Sozzi, Orazio Fortunato
Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling. Molecular oncology 15 (11) (2021)
Orazio Fortunato, Marilena V Iorio
The Therapeutic Potential of MicroRNAs in Cancer: Illusion or Opportunity? Pharmaceuticals (Basel, Switzerland) 13 (12) (2020)